95 related articles for article (PubMed ID: 4317645)
1. [Some data from a biochemical study of patients with primary cancer of the liver during chemotherapy].
Pashintseva LP; Krusanova NI; Assekritova IV
Vestn Akad Med Nauk SSSR; 1970; 25(2):39-43. PubMed ID: 4317645
[No Abstract] [Full Text] [Related]
2. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.
Jiang W; Lu Z; He Y; Diasio RB
Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697
[TBL] [Abstract][Full Text] [Related]
3. Biochemical profile in liver cancer patients.
Rasheed A; Iqtidar A
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):366-7. PubMed ID: 7668112
[TBL] [Abstract][Full Text] [Related]
4. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
Noda T; Nagano H; Marubashi S; Kobayashi S; Takeda Y; Murakami M; Tomimaru Y; Dono K; Umeshita K; Nakayama M; Shima T; Wakasa K; Monden M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2099-102. PubMed ID: 19106536
[TBL] [Abstract][Full Text] [Related]
5. Continuous prolonged intrahepatic infusion of 5-fluorouracil in the treatment of hepatoma in Ibadan.
Francis TI
West Afr Med J Niger Pract; 1972 Feb; 21(1):18-20. PubMed ID: 4338412
[No Abstract] [Full Text] [Related]
6. [Selective chemotherapy of hepatocellular carcinomas].
Keppler D; Pausch J; Gerok W
Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
[No Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
[TBL] [Abstract][Full Text] [Related]
8. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial.
Kawata S; Yamasaki E; Nagase T; Inui Y; Ito N; Matsuda Y; Inada M; Tamura S; Noda S; Imai Y; Matsuzawa Y
Br J Cancer; 2001 Apr; 84(7):886-91. PubMed ID: 11286466
[TBL] [Abstract][Full Text] [Related]
9. [Apropos of a hepatoma: rôle of regional chemotherapy].
Bessot M; Thevenin F; Fays J; Grilliat JP
Sem Hop; 1968 Jun; 44(29):1995-6. PubMed ID: 4299982
[No Abstract] [Full Text] [Related]
10. Prolonged survival with hepatocellular carcinoma.
Penalba C; Larouze B; Mechali D; Saimot G; Coulaud JP
Gastroenterology; 1982 Nov; 83(5):1159. PubMed ID: 6288508
[No Abstract] [Full Text] [Related]
11. Hepatoma: long-term survival with disseminated tumor treated with 5-fluorouracil.
Ramirez G; Ansfield FJ; Curreri AR
Am J Surg; 1970 Sep; 120(3):400-3. PubMed ID: 4318569
[No Abstract] [Full Text] [Related]
12. Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.
Ueno H; Okada S; Okusaka T; Ikeda M; Kuriyama H
Cancer Chemother Pharmacol; 2002 Feb; 49(2):155-60. PubMed ID: 11862430
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
Chan KK; Chlebowski RT; Tong M; Chen HS; Gross JF; Bateman JR
Cancer Res; 1980 Apr; 40(4):1263-8. PubMed ID: 6244090
[No Abstract] [Full Text] [Related]
14. Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
Franchi F; Ielapi T; Bizzarri M; Seminara P
J Gastroenterol Hepatol; 2005 Sep; 20(9):1467-8. PubMed ID: 16105144
[No Abstract] [Full Text] [Related]
15. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
[TBL] [Abstract][Full Text] [Related]
17. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.
Cochrane AM; Murray-Lyon IM; Brinkley DM; Williams R
Cancer; 1977 Aug; 40(2):609-14. PubMed ID: 196734
[No Abstract] [Full Text] [Related]
18. Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.
Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
Cancer Chemother Pharmacol; 2008 Nov; 62(6):959-63. PubMed ID: 18259753
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
[TBL] [Abstract][Full Text] [Related]
20. [Effects of selective administration of anticancer agents in massive dosage combined with fibrolytic enzyme (urokinase) in hepatic cancer].
Daido R; Koike A; Nomiyama Y; Nakamura M; Watanabe T
Gan No Rinsho; 1972 Apr; 18(4):285-9. PubMed ID: 4337719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
